In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin

Hyo Jeong Lee, Hyo Jung Lee, Eun Ok Lee, Jae Ho Lee, Kuen Sung Lee, Kwan Hyun Kim, Sung Hoon Kim, Junxuan Lu

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

We have reported that a 10-herbal traditional formula containing Korean Angelica gigas Nakai (AGN) exerts potent anti-cancer efficacy and identified decursin and decursinol angelate (DA) from AGN as novel anti-androgens. Here, we determined whether AGN would exert in vivo anti-cancer activity and whether decursin or DA could account for its efficacy. The AGN ethanol extract was tested against the growth of mouse Lewis lung cancer (LLC) allograft in syngenic mice or human PC-3 and DU145 prostate cancer xenograft in immunodeficient mice. The pharmacokinetics of decursin and DA were determined. The AGN extract significantly inhibited LLC allograft growth (30 mg/kg) and PC-3 and DU145 xenograft growth (100 mg/kg) without affecting the body weight of the host mice. Biomarker analyses revealed decreased cell proliferation (Ki67, PCNA), decreased angiogenesis (VEGF, microvessel density) and increased apoptosis (TUNEL, cPARP) in treated tumors. Decursin and DA injected intraperitoneally were rapidly hydrolyzed to decursinol. Decursinol and decursin at 50 mg/kg inhibited LLC allograft growth to the same extent, comparable to 30 mg AGN/kg. Therefore the AGN extract possessed significant in vivo anti-cancer activity, but decursin and DA only contributed moderately to that activity, most likely through decursinol.

Original languageEnglish (US)
Pages (from-to)127-142
Number of pages16
JournalAmerican Journal of Chinese Medicine
Volume37
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Pyranocoumarins
Angelica
Neoplasms
Allografts
Lung Neoplasms
Growth
decursin
Heterografts

All Science Journal Classification (ASJC) codes

  • Complementary and alternative medicine

Cite this

Lee, Hyo Jeong ; Lee, Hyo Jung ; Lee, Eun Ok ; Lee, Jae Ho ; Lee, Kuen Sung ; Kim, Kwan Hyun ; Kim, Sung Hoon ; Lu, Junxuan. / In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. In: American Journal of Chinese Medicine. 2009 ; Vol. 37, No. 1. pp. 127-142.
@article{2d60c80e28834935bcbf897d48d2c539,
title = "In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin",
abstract = "We have reported that a 10-herbal traditional formula containing Korean Angelica gigas Nakai (AGN) exerts potent anti-cancer efficacy and identified decursin and decursinol angelate (DA) from AGN as novel anti-androgens. Here, we determined whether AGN would exert in vivo anti-cancer activity and whether decursin or DA could account for its efficacy. The AGN ethanol extract was tested against the growth of mouse Lewis lung cancer (LLC) allograft in syngenic mice or human PC-3 and DU145 prostate cancer xenograft in immunodeficient mice. The pharmacokinetics of decursin and DA were determined. The AGN extract significantly inhibited LLC allograft growth (30 mg/kg) and PC-3 and DU145 xenograft growth (100 mg/kg) without affecting the body weight of the host mice. Biomarker analyses revealed decreased cell proliferation (Ki67, PCNA), decreased angiogenesis (VEGF, microvessel density) and increased apoptosis (TUNEL, cPARP) in treated tumors. Decursin and DA injected intraperitoneally were rapidly hydrolyzed to decursinol. Decursinol and decursin at 50 mg/kg inhibited LLC allograft growth to the same extent, comparable to 30 mg AGN/kg. Therefore the AGN extract possessed significant in vivo anti-cancer activity, but decursin and DA only contributed moderately to that activity, most likely through decursinol.",
author = "Lee, {Hyo Jeong} and Lee, {Hyo Jung} and Lee, {Eun Ok} and Lee, {Jae Ho} and Lee, {Kuen Sung} and Kim, {Kwan Hyun} and Kim, {Sung Hoon} and Junxuan Lu",
year = "2009",
month = "1",
day = "1",
doi = "10.1142/S0192415X09006722",
language = "English (US)",
volume = "37",
pages = "127--142",
journal = "American Journal of Chinese Medicine",
issn = "0192-415X",
publisher = "World Scientific Publishing Co. Pte Ltd",
number = "1",

}

In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. / Lee, Hyo Jeong; Lee, Hyo Jung; Lee, Eun Ok; Lee, Jae Ho; Lee, Kuen Sung; Kim, Kwan Hyun; Kim, Sung Hoon; Lu, Junxuan.

In: American Journal of Chinese Medicine, Vol. 37, No. 1, 01.01.2009, p. 127-142.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin

AU - Lee, Hyo Jeong

AU - Lee, Hyo Jung

AU - Lee, Eun Ok

AU - Lee, Jae Ho

AU - Lee, Kuen Sung

AU - Kim, Kwan Hyun

AU - Kim, Sung Hoon

AU - Lu, Junxuan

PY - 2009/1/1

Y1 - 2009/1/1

N2 - We have reported that a 10-herbal traditional formula containing Korean Angelica gigas Nakai (AGN) exerts potent anti-cancer efficacy and identified decursin and decursinol angelate (DA) from AGN as novel anti-androgens. Here, we determined whether AGN would exert in vivo anti-cancer activity and whether decursin or DA could account for its efficacy. The AGN ethanol extract was tested against the growth of mouse Lewis lung cancer (LLC) allograft in syngenic mice or human PC-3 and DU145 prostate cancer xenograft in immunodeficient mice. The pharmacokinetics of decursin and DA were determined. The AGN extract significantly inhibited LLC allograft growth (30 mg/kg) and PC-3 and DU145 xenograft growth (100 mg/kg) without affecting the body weight of the host mice. Biomarker analyses revealed decreased cell proliferation (Ki67, PCNA), decreased angiogenesis (VEGF, microvessel density) and increased apoptosis (TUNEL, cPARP) in treated tumors. Decursin and DA injected intraperitoneally were rapidly hydrolyzed to decursinol. Decursinol and decursin at 50 mg/kg inhibited LLC allograft growth to the same extent, comparable to 30 mg AGN/kg. Therefore the AGN extract possessed significant in vivo anti-cancer activity, but decursin and DA only contributed moderately to that activity, most likely through decursinol.

AB - We have reported that a 10-herbal traditional formula containing Korean Angelica gigas Nakai (AGN) exerts potent anti-cancer efficacy and identified decursin and decursinol angelate (DA) from AGN as novel anti-androgens. Here, we determined whether AGN would exert in vivo anti-cancer activity and whether decursin or DA could account for its efficacy. The AGN ethanol extract was tested against the growth of mouse Lewis lung cancer (LLC) allograft in syngenic mice or human PC-3 and DU145 prostate cancer xenograft in immunodeficient mice. The pharmacokinetics of decursin and DA were determined. The AGN extract significantly inhibited LLC allograft growth (30 mg/kg) and PC-3 and DU145 xenograft growth (100 mg/kg) without affecting the body weight of the host mice. Biomarker analyses revealed decreased cell proliferation (Ki67, PCNA), decreased angiogenesis (VEGF, microvessel density) and increased apoptosis (TUNEL, cPARP) in treated tumors. Decursin and DA injected intraperitoneally were rapidly hydrolyzed to decursinol. Decursinol and decursin at 50 mg/kg inhibited LLC allograft growth to the same extent, comparable to 30 mg AGN/kg. Therefore the AGN extract possessed significant in vivo anti-cancer activity, but decursin and DA only contributed moderately to that activity, most likely through decursinol.

UR - http://www.scopus.com/inward/record.url?scp=65449129220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449129220&partnerID=8YFLogxK

U2 - 10.1142/S0192415X09006722

DO - 10.1142/S0192415X09006722

M3 - Article

C2 - 19222117

AN - SCOPUS:65449129220

VL - 37

SP - 127

EP - 142

JO - American Journal of Chinese Medicine

JF - American Journal of Chinese Medicine

SN - 0192-415X

IS - 1

ER -